Edited by Daniel K. Podolsky, Michael Camilleri, J.
Gregory Fitz,
Anthony
N. Kalloo, Fergus Shanahan, Timothy C. Wang
1. BusseyHJR. Familial Polyposis Coli. Family Studies, Histopathology, Differential Diagnosis and Results of Treatment. Baltimore: Johns Hopkins University Press; 1975.
2. GardnerEJ, BurtRW, FrestonJW. Gastrointestinal polyposis: syndromes and genetic mechanisms. West J Med1980;132:488.
3. JaspersonKW, TuohyTM, NeklasonDW, et al.Hereditary and familial colon cancer. Gastroenterology2010;138:2044. CrossRef
4. VasenHF, MosleinG, AlonsoA, et al.Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut2008;57:704. CrossRef
5. GaliatsatosP, FoulkesWD. Familial adenomatous polyposis. Am J Gastroenterol2006;101:385. CrossRef
6. JarvinenHJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut1992;33:357. CrossRef
7. BulowS, Faurschou NielsenT, BulowC, et al.The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis1996;11:88. CrossRef
8. BisgaardML, FengerK, BulowS, et al.Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat1994;3:121. CrossRef
9. BjorkJ, AkerbrantH, IseliusL, et al.Epidemiology of familial adenomatous polyposis in Sweden: changes over time and differences in phenotype between males and females. Scand J Gastroenterol1999;34:1230. CrossRef
10. IwamaT, TamuraK, MoritaT, et al.A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol2004;9:308. CrossRef
11. ScheunerMT, McNeelTS, FreedmanAN. Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med2010;12:726. CrossRef
12. AretzS, UhlhaasS, CaspariR, et al.Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet2004;12:52. CrossRef
13. AretzS, StienenD, FriedrichsN, et al.Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP). Hum Mutat2007;28:985. CrossRef
14. HesFJ, NielsenM, BikEC, et al.Somatic APC mosaicism: an underestimated cause of polyposis coli. Gut2008;57:71. CrossRef
15. SchwabAL, TuohyTM, CondieM, et al.Gonadal mosaicism and familial adenomatous polyposis. Fam Cancer2008;7:173. CrossRef
16. TuohyTM, BurtRW. Somatic mosaicism: a cause for unexplained cases of FAP?Gut2008;57:10. CrossRef
17. PerchiniakEM, GrodenJ. Mechanisms regulating microtubule binding, DNA replication, and apoptosis are controlled by the intestinal tumor suppressor APC. Curr Colorectal Cancer Rep2011;7:145. CrossRef
18. BurtR, NeklasonDW. Genetic testing for inherited colon cancer. Gastroenterology2005;128:1696. CrossRef
19. ChungDC. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology2000;119:854. CrossRef
20. GossKH, GrodenJ. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol2000;18:1967.
21. NathkeI. APC at a glance. J Cell Sci2004;117:4873. CrossRef
22. QianJ, SarnaikAA, BonneyTM, et al.The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus. Gastroenterology2008;135:152. CrossRef
23. NieuwenhuisMH, VasenHF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol2007;61:153. CrossRef
24. YamashitaYM, JonesDL, FullerMT. Orientation of asymmetric stem cell division by the APC tumor suppressor and centrosome. Science2003;301:1547. CrossRef
25. Etienne‐MannevilleS, HallA. Cdc42 regulates GSK‐3beta and adenomatous polyposis coli to control cell polarity. Nature2003;421:753. CrossRef
26. FlintoffKJ, SheridanE, TurnerG, et al.Submicroscopic deletions of the APC gene: a frequent cause of familial adenomatous polyposis that may be overlooked by conventional mutation scanning. J Med Genet2001;38:129. CrossRef
27. AretzS, StienenD, UhlhaasS, et al.Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis. J Med Genet2005;42:185. CrossRef
28. MichilsG, TejparS, ThoelenR, et al.Large deletions of the APC gene in 15% of mutation‐negative patients with classical polyposis (FAP): a Belgian study. Hum Mutat2005;25:125. CrossRef
29. NagaseH, NakamuraY. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutat1993;2:425. CrossRef
30. GrovesC, LamlumH, CrabtreeM, et al.Mutation cluster region, association between germline and somatic mutations and genotype‐phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol2002;160:2055. CrossRef
31. RenkonenET, NieminenP, Abdel‐RahmanWM, et al.Adenomatous polyposis families that screen APC mutation‐negative by conventional methods are genetically heterogeneous. J Clin Oncol2005;23:5651. CrossRef
32. MeullerJ, Kanter‐SmolerG, NygrenAO, et al.Identification of genomic deletions of the APC gene in familial adenomatous polyposis by two independent quantitative techniques. Genet Test2004;8:248. CrossRef
33. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol2003;21:2397. CrossRef
34. TrimbathJD, GiardielloFM. Genetic testing and counselling for hereditary colorectal cancer. Aliment Pharmacol Ther2002;16:1843. CrossRef
35. NielsenM, BikE, HesFJ, et al.Genotype‐phenotype correlations in 19 Dutch cases with APC gene deletions and a literature review. Eur J Hum Genet2007;15:1034. CrossRef
36. PetersenGM, SlackJ, NakamuraY. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology1991;100:1658.
37. LiG, TamuraK, YamamotoY, et al.Molecular and clinical study of familial adenomatous polyposis for genetic testing and management. J Exp Clin Cancer Res1999;18:519.
38. FriedlW, CaspariR, SengtellerM, et al.Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut2001;48:515. CrossRef
39. GiardielloFM, KrushAJ, PetersenGM, et al.Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology1994;106:1542.
40. RoncucciL, StampD, MedlineA, et al.Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol1991;22:287. CrossRef
41. BulowS. Results of national registration of familial adenomatous polyposis. Gut2003;52:742. CrossRef
42. GibbonsDC, SinhaA, PhillipsRK, et al.Colorectal cancer: no longer the issue in familial adenomatous polyposis?Fam Cancer2011;10:11. CrossRef
43. DebinskiHS, LoveS, SpigelmanAD, et al.Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology1996;110:1028. CrossRef
44. JangYS, SteinhagenRM, HeimannTM. Colorectal cancer in familial adenomatous polyposis. Dis Colon Rectum1997;40:312. CrossRef
45. BurtRW. Gastric fundic gland polyps. Gastroenterology2003;125:1462. CrossRef
46. BulowS, BjorkJ, ChristensenIJ, et al.Duodenal adenomatosis in familial adenomatous polyposis. Gut2004;53:381. CrossRef
47. WestonBR, HelperDJ, RexDK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol2003;36:399. CrossRef
48. ZwickA, MunirM, RyanCK, et al.Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology1997;113:659. CrossRef
49. HofgartnerWT, ThorpM, RamusMW, et al.Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol1999;94:2275. CrossRef
50. AttardTM, GiardielloFM, ArganiP, et al.Fundic gland polyposis with high‐grade dysplasia in a child with attenuated familial adenomatous polyposis and familial gastric cancer. J Pediatr Gastroenterol Nutr2001;32:215. CrossRef
51. BianchiLK, BurkeCA, BennettAE, et al.Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol2008;6:180. CrossRef
52. WuTT, KornackiS, RashidA, et al.Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol1998;22:293. CrossRef
53. BertoniG, SassatelliR, NigrisoliE, et al.Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. Ital J Gastroenterol Hepatol1999;31:192.
54. GarreanS, HeringJ, SaiedA, et al.Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome. Am Surg2008;74:79.
55. LynchHT, SnyderC, DaviesJM, et al.FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review. Fam Cancer2010;9:581. CrossRef
56. AbrahamSC, NobukawaB, GiardielloFM, et al.Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta‐catenin gene. Am J Pathol2001;158:1005. CrossRef
57. SekineS, ShibataT, YamauchiY, et al.Beta‐catenin mutations in sporadic fundic gland polyps. Virchows Arch2002;440:381. CrossRef
58. AbrahamSC, NobukawaB, GiardielloFM, et al.Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol2000;157:747. CrossRef
59. NakamuraS, MatsumotoT, KoboriY, et al.Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis. Gut2002;51:485. CrossRef
60. SawadaT, MutoT. Role of upper gastrointestinal surveillance in patients with familial adenomatous polyposis. Gastrointest Endosc Clin N Am1997;7:99.
61. WallaceMH, PhillipsRK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg1998;85:742. CrossRef
62. Lopez‐CeronM, van den BroekFJ, Mathus‐VliegenEM, et al.The role of high‐resolution endoscopy and narrow‐band imaging in the evaluation of upper GI neoplasia in familial adenomatous polyposis. Gastrointest Endosc2013;77:542. CrossRef
63. SpigelmanAD, WilliamsCB, TalbotIC, et al.Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet1989;2:783. CrossRef
64. GrovesCJ, SaundersBP, SpigelmanAD, et al.Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut2002;50:636. CrossRef
65. SaurinJC, GutknechtC, NapoleonB, et al.Surveillance of duodenal adenomas in familial adenomatous polyposis reveals high cumulative risk of advanced disease. J Clin Oncol2004;22:493. CrossRef
66. BjorkJ, AkerbrantH, IseliusL, et al.Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology2001;121:1127. CrossRef
67. LatchfordAR, NealeKF, SpigelmanAD, et al.Features of duodenal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol2009;7:659. CrossRef
68. DriniM, SpeerA, DowC, et al.Management of duodenal adenomatosis in FAP: single centre experience. Fam Cancer2012;11:167. CrossRef
69. IaquintoG, FornasarigM, QuaiaM, et al.Capsule endoscopy is useful and safe for small‐bowel surveillance in familial adenomatous polyposis. Gastrointest Endosc2008;67:61. CrossRef
70. TulchinskyH, KeidarA, StrulH, et al.Extracolonic manifestations of familial adenomatous polyposis after proctocolectomy. Arch Surg2005;140:159. CrossRef
71. BertarioL, RussoA, SalaP, et al.Multiple approach to the exploration of genotype‐phenotype correlations in familial adenomatous polyposis. J Clin Oncol2003;21:1698. CrossRef
72. SpigelmanAD, PhillipsRKS. The upper gastrointestinal tract. In: PhillipsRKS, SpigelmanAD, ThomasonJPS(eds). Familial Adenomatous Polyposis and Other Syndromes. London: Edward Arnold; 1994: 106.
73. TytgatGN. Surveillance of familial adenomatous polyposis patients after ileorectal anastomosis or ileoanal pouch anastomosis. Gastrointest Endosc Clin N Am1997;7:111.
74. AlderliesteYA, RauwsEA, Mathus‐VliegenEM, et al.Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis. Fam Cancer2013;12:51. CrossRef
75. RuysAT, AlderliesteYA, GoumaDJ, et al.Jejunal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol2010;8:731. CrossRef
76. FriederichP, de JongAE, Mathus‐VliegenLM, et al.Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol2008;6:1237. CrossRef
77. TajikaM, NakamuraT, NakaharaO, et al.Prevalence of adenomas and carcinomas in the ileal pouch after proctocolectomy in patients with familial adenomatous polyposis. J Gastrointest Surg2009;13:1266. CrossRef
78. CamposFG, ImperialeAR, SeidVE, et al.Rectal and pouch recurrences after surgical treatment for familial adenomatous polyposis. J Gastrointest Surg2009;13:129. CrossRef
79. KurtzRC, SternbergSS, MillerHH, et al.Upper gastrointestinal neoplasia in familial polyposis. Dig Dis Sci1987;32:459. CrossRef
80. JagelmanDG, DeCosseJJ, BusseyHJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet1988;1:1149. CrossRef
81. WalshN, QizilbashA, BanerjeeR, et al.Biliary neoplasia in Gardner's syndrome. Arch Patholol Lab Med1987;111:76.
82. BrevetM, BrehantO, DumontF, et al.[Adenomatous polyposis of the gallbladder and Gardner's syndrome. A rare association]. Gastroenterol Clin Biol2007;31:425. CrossRef
83. GardnerEJ, PlenkHP. Hereditary pattern for multiple osteomas in a family group. Am J Hum Genet1952;4:31.
84. GardnerEJ. Follow‐up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermoid cysts. Am J Hum Genet1962;14:376.
85. BilkayU, ErdemO, OzekC, et al.Benign osteoma with Gardner syndrome: review of the literature and report of a case. J Craniofac Surg2004;15:506. CrossRef
86. WijnMA, KellerJJ, GiardielloFM, et al.Oral and maxillofacial manifestations of familial adenomatous polyposis. Oral Dis2007;13:360. CrossRef
87. BisgaardML, BulowS. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A2006;140:200. CrossRef
88. BrettMCA, HershmanMJ, GlazerG. Other manifestations of familial adenomatous polyposis. In: PhillipsRKS, SpigelmanAD, ThomasonJPS(eds). Familial Adenomatous Polyposis and Other Polyposis Syndromes. London: Edward Arnold; 1994: 143.
89. TakeuchiT, TakenoshitaY, KuboK, et al.Natural course of jaw lesions in patients with familial adenomatosis coli (Gardner's syndrome). Int J Oral Maxillofac Surg1993;22:226. CrossRef
90. GiardielloFM, OfferhausGJ, TraboulsiEI, et al.Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis. Gut1991;32:1170. CrossRef
91. OfferhausGJ, LevinLS, GiardielloFM, et al.Occult radiopaque jaw lesions in familial adenomatous polyposis coli and hereditary nonpolyposis colorectal cancer. Gastroenterology1987;93:490.
92. KuboK, MiyataniH, TakenoshitaY, et al.Widespread radiopacity of jaw bones in familial adenomatosis coli. J Craniomaxillofac Surg1989;17:350. CrossRef
93. OkuT, TakayamaT, SatoY, et al.A case of Gardner syndrome with a mutation at codon 1556 of APC: a suggested case of genotype‐phenotype correlation in dental abnormality. Eur J Gastroenterol Hepatol2004;16:101. CrossRef
94. GardnerEJ, RichardsRC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet1953;5:139.
95. SenerSF, MillerHH, DeCosseJJ. The spectrum of polyposis. Surg Gynecol Obstet1984;159:525.
96. BusseyHJ, VealeAM, MorsonBC. Genetics of gastrointestinal polyposis. Gastroenterology1978;74:1325.
97. LeppardBJ. Epidermoid cysts and polyposis coli. Proc R Soc Med1974;67:1036.
98. OldfieldMC. The association of familial polyposis of the colon with multiple sebaceous cysts. Br J Surg1954;41:534. CrossRef
99. PujolRM, CasanovaJM, EgidoR, et al.Multiple familial pilomatricomas: a cutaneous marker for Gardner syndrome?Pediatr Dermatol1995;12:331. CrossRef
100. AzzarelliA, GronchiA, BertulliR, et al.Low‐dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer2001;92:1259. CrossRef
101. EscobarC, MunkerR, ThomasJO, et al.Update on desmoid tumors. Ann Oncol2012;23:562. CrossRef
102. ClarkSK, NealeKF, LandgrebeJC, et al.Desmoid tumours complicating familial adenomatous polyposis. Br J Surg1999;86:1185. CrossRef
103. FarmerKCR, HawleyPR, PhillipsRKS. Desmoid disease. In: PhillipsRKS, SpigelmanAD, ThomasonJPS(eds). Familial Adenomatous Polyposis and Other Polyposis Syndromes. London: Edward Arnold; 1994: 128.
104. HeiskanenI, JarvinenHJ. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis1996;11:157. CrossRef
105. SturtNJH, GallagherMC, BassettP, et al.Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut2004;53:1832. CrossRef
106. DurnoC, MongaN, BapatB, et al.Does early colectomy increase desmoid risk in familial adenomatous polyposis?Clin Gastroenterol Hepatol2007;5:1190. CrossRef
107. LatchfordAR, SturtNJ, NealeK, et al.A 10‐year review of surgery for desmoid disease associated with familial adenomatous polyposis. Br J Surg2006;93:1258. CrossRef
108. SinhaA, TekkisPP, GibbonsDC, et al.Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta‐analysis. Colorectal Dis2011;13:1222. CrossRef
109. BertarioL, RussoA, SalaP, et al.Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer2001;95:102. CrossRef
110. NieuwenhuisMH, De Vos Tot Nederveen CappelW, BotmaA, et al.Desmoid tumors in a dutch cohort of patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol2008;6:215. CrossRef
111. SoraviaC, BerkT, McLeodRS, et al.Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum2000;43:363. CrossRef
112. SinhaA, GibbonsDC, PhillipsRK, et al.Surgical prophylaxis in familial adenomatous polyposis: do pre‐existing desmoids outside the abdominal cavity matter?Fam Cancer2010;9:407. CrossRef
113. SpeakeD, EvansDG, LallooF, et al.Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations. Br J Surg2007;94:1009. CrossRef
114. ParcY, PiquardA, DozoisRR, et al.Long‐term outcome of familial adenomatous polyposis patients after restorative coloproctectomy. Ann Surg2004;239:378. CrossRef
115. SturtNJ, ClarkSK. Current ideas in desmoid tumours. Fam Cancer2006;5:275. CrossRef
116. BertagnolliMM, MorganJA, FletcherCD, et al.Multimodality treatment of mesenteric desmoid tumours. Eur J Cancer2008;44:2404. CrossRef
117. FallenT, WilsonM, MorlanB, et al.Desmoid tumors – a characterization of patients seen at mayo clinic 1976–1999. Fam Cancer2006;5:191. CrossRef
118. PhoLN, CoffinCM, BurtRW. Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion. Fam Cancer2005;4:135. CrossRef
119. ClarkSK, SmithTG, KatzDE, et al.Identification and progression of a desmoid precursor lesion in patients with familial adenomatous polyposis. Br J Surg1998;85:970. CrossRef
120. CalvertGT, MonumentMJ, BurtRW, et al.Extra‐abdominal desmoid tumors associated with familial adenomatous polyposis. Sarcoma2012;2012:726537.
121. SamadderNJ, JaspersonK, BurtRW. A pain in the neck and colon polyps. Gastroenterology2012;142:1073. CrossRef
122. EcclesDM, van der LuijtR, BreukelC, et al.Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet1996;59:1193.
123. ScottRJ, FroggattNJ, TrembathRC, et al.Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet1996;5:1921. CrossRef
124. CoffinCM, HornickJL, ZhouH, et al.Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol2007;31:410. CrossRef
125. KotiligamD, LazarAJ, PollockRE, et al.Desmoid tumor: a disease opportune for molecular insights. Histol Histopathol2008;23:117.
126. TraboulsiEI, KrushAJ, GardnerEJ, et al.Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med1987;316:661. CrossRef
127. TourinoR, Conde‐FreireR, Cabezas‐AgricolaJM, et al.Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. Int Ophthalmol2004;25:101. CrossRef
128. PainterTA, JagelmanDG. Adrenal adenomas and adrenal carcinomas in association with hereditary adenomatosis of the colon and rectum. Cancer1985;55:2001. CrossRef
129. FerrandezA, PhoL, SolomonC, et al.An evidence‐based, multidisciplinary approach to the clinical considerations, management, and surveillance of adrenal lesions in familial adenomatous polyposis: report of three cases. Dis Colon Rectum2006;49:1781. CrossRef
130. MarchesaP, FazioVW, ChurchJM, et al.Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum1997;40:1023. CrossRef
131. SmithTG, ClarkSK, KatzDE, et al.Adrenal masses are associated with familial adenomatous polyposis. Dis Colon Rectum2000;43:1739. CrossRef
132. YoungWFJr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med2007;356:601. CrossRef
133. GiardielloFM, HamiltonSR, KrushAJ, et al.Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology1993;105:1550. CrossRef
134. ValanzanoR, CuriaMC, AcetoG, et al.Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour. Gut2005;54:1046. CrossRef
135. YoungJ, BarkerM, RobertsonT, et al.A case of myoepithelial carcinoma displaying biallelic inactivation of the tumour suppressor gene APC in a patient with familial adenomatous polyposis. J Clin Pathol2002;55:230. CrossRef
136. MaireF, HammelP, TerrisB, et al.Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut2002;51:446. CrossRef
137. HerraizM, BarbesinoG, FaquinW, et al.Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol2007;5:367. CrossRef
138. CettaF, MontaltoG, GoriM, et al.Germline mutations of the APC gene in patients with familial adenomatous polyposis‐associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab2000;85:286.
139. GiardielloFM, OfferhausGJA, KrushAJ, et al.Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut1993;34:1394. CrossRef
140. TrutaB, AllenBA, ConradPG, et al.Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Fam Cancer2003;2:95. CrossRef
141. GiardielloFM, PetersenGM, BrensingerJD, et al.Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut1996;39:867. CrossRef
142. AretzS, KochA, UhlhaasS, et al.Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?Pediatr Blood Cancer2006;47:811. CrossRef
143. HirschmanBA, PollockBH, TomlinsonGE. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr2005;147:263. CrossRef
144. SandersRP, FurmanWL. Familial adenomatous polyposis in two brothers with hepatoblastoma: implications for diagnosis and screening. Pediatr Blood Cancer2006;47:851. CrossRef
145. NieuwenhuisMH, Mathus‐VliegenLM, SlorsFJ, et al.Genotype‐phenotype correlations as a guide in the management of familial adenomatous polyposis. Clin Gastroenterol Hepatol2007;5:374. CrossRef
146. TurcotJ, DespresJ‐P, St. PierreF. Malignant tumors of the central nervous system associated with familial polyposis of the colon. Dis Colon Rectum1959;2:465. CrossRef
147. HamiltonSR, LiuB, ParsonsRE, et al.The molecular basis of Turcot's syndrome. N Engl J Med1995;332:839. CrossRef
148. ParafF, JothyS, Van MeirEG. Brain tumor‐polyposis syndrome: two genetic diseases?J Clin Oncol1997;15:2744.
149. BurtRW, LeppertMF, SlatteryML, et al.Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology2004;127:444. CrossRef
150. HerneggerGS, MooreHG, GuillemJG. Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum2002;45:127. CrossRef
151. KnudsenAL, BisgaardML, BulowS. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer2003;2:43. CrossRef
152. GroverS, KastrinosF, SteyerbergEW, et al.Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA2012;308:485. CrossRef
153. NeklasonDW, StevensJ, BoucherKM, et al.American founder mutation for attenuated familial adenomatous polyposis. Clin Gastroenterol Hepatol2008;I6:46. CrossRef
154. CastellsagueE, GonzalezS, GuinoE, et al.Allele‐specific expression of APC in adenomatous polyposis families. Gastroenterology2010;139:439. CrossRef
155. CattaneoF, MolatoreS, MihalatosM, et al.Heterogeneous molecular mechanisms underlie attenuated familial adenomatous polyposis. Genet Med2007;9:836. CrossRef
156. SieberO, SegditsasS, KnudsenA, et al.Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly, but depend on the site of the germline mutation. Gut2006.
157. TuohyTM, DoneMW, LewandowskiMS, et al.Large intron 14 rearrangement in APC results in splice defect and attenuated FAP. Hum Genet2010;127:356. CrossRef
158. VenesioT, BalsamoA, SfiligoiC, et al.Constitutional high expression of an APC mRNA isoform in a subset of attenuated familial adenomatous polyposis patients. J Mol Med2007;85:305. CrossRef
159. PallesC, CazierJB, HowarthKM, et al.Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet2013;45:136. CrossRef
160. CaoY, PierettiM, MarshallJ, et al.Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature. Am J Gastroenterol2002;97:1822. CrossRef
161. HeiskanenI, LuostarinenT, JarvinenHJ. Impact of screening examinations on survival in familial adenomatous polyposis. Scand J Gastroenterol2000;35:1284. CrossRef
162. ArvanitisML, JagelmanDG, FazioVW, et al.Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum1990;33:639. CrossRef
163. BelchetzLA, BerkT, BapatBV, et al.Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum1996;39:384. CrossRef
164. NugentKP, SpigelmanAD, PhillipsRK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum1993;36:1059. CrossRef
165. NugentKP, SpigelmanAD, PhillipsRK. Risk of extracolonic cancer in familial adenomatous polyposis. Br J Surg1996;83:1121. CrossRef
166. LindorNM. Recognition of genetic syndromes in families with suspected hereditary colon cancer syndromes. Clin Gastroenterol Hepatol2004;2:366. CrossRef
167. BjorkJA, AkerbrantHI, IseliusLE, et al.Risk factors for rectal cancer morbidity and mortality in patients with familial adenomatous polyposis after colectomy and ileorectal anastomosis. Dis Colon Rectum2000;43:1719. CrossRef
168. GiardielloFM, BrensingerJD, PetersenGM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology2001;121:198. CrossRef
169. BurtRW. Colon cancer screening. Gastroenterology2000;119:837. CrossRef
170. GuillemJG, SmithAJ, CulleJ, et al.Gastrointestinal polyposis syndromes. Curr Probl Surg1999;36:217. CrossRef
171. KinneyAY, HickenB, SimonsenSE, et al.Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families. Am J Gastroenterol2007;102:153. CrossRef
172. KadmonM, TandaraA, HerfarthC. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis2001;16:63. CrossRef
173. AttardTM, CuffariC, TajouriT, et al.Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol2004;99:681. CrossRef
174. HondaW, OhmiyaN, HirookaY, et al.Enteroscopic and radiologic diagnoses, treatment, and prognoses of small‐bowel tumors. Gastrointest Endosc2012;76:344. CrossRef
175. TescherP, MacraeFA, SpeerT, et al.Surveillance of FAP: a prospective blinded comparison of capsule endoscopy and other GI imaging to detect small bowel polyps. Hered Cancer Clin Pract2010;8:3. CrossRef
176. ParcYR, OlschwangS, DesaintB, et al.Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy. Ann Surg2001;233:360. CrossRef
177. GrovesCJ, BeveridgeG, SwainDJ, et al.Prevalence and morphology of pouch and ileal adenomas in familial adenomatous polyposis. Dis Colon Rectum2005;48:816. CrossRef
178. OoiBS, RemziFH, GramlichT, et al.Anal transitional zone cancer after restorative proctocolectomy and ileoanal anastomosis in familial adenomatous polyposis: report of two cases. Dis Colon Rectum2003;46:1418. CrossRef
179. ChurchJ. Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat. Dis Colon Rectum2005;48:1708. CrossRef
180. FeinbergSM, JagelmanDG, SarreRG, et al.Spontaneous resolution of rectal polyps in patients with familial polyposis following abdominal colectomy and ileorectal anastomosis. Dis Colon Rectum1988;31:169. CrossRef
181. MorpurgoE, VitaleGC, GalandiukS, et al.Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas. J Gastrointest Surg2004;8:559. CrossRef
182. BülowC, VasenH, JärvinenH, et al.Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology2000;119:1454. CrossRef
183. NieuwenhuisMH, BulowS, BjorkJ, et al.Genotype predicting phenotype in familial adenomatous polyposis: a practical application to the choice of surgery. Dis Colon Rectum2009;52:1259. CrossRef
184. da Luz MoreiraA, ChurchJM, BurkeCA. The evolution of prophylactic colorectal surgery for familial adenomatous polyposis. Dis Colon Rectum2009;52:1481. CrossRef
185. KartheuserA, StangherlinP, BrandtD, et al.Restorative proctocolectomy and ileal pouch‐anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer2006;5:241. CrossRef
186. de Vos tot Nederveen CappelWH, JarvinenHJ, BjorkJ, et al.Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg2003;90:705. CrossRef
187. BrosensLA, KellerJJ, OfferhausGJ, et al.Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut2005;54:1034. CrossRef
188. BalmforthDC, PhillipsRK, ClarkSK. Advanced duodenal disease in familial adenomatous polyposis: how frequently should patients be followed up after successful therapy?Fam Cancer2012;11:553. CrossRef
189. NieuwenhuisMH, Mathus‐VliegenEM, BaetenCG, et al.Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer2011;104:37. CrossRef
190. GegaM, YanagiH, YoshikawaR, et al.Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis. J Clin Oncol2006;24:102. CrossRef
191. SkapekSX, FergusonWS, GranowetterL, et al.Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol2007;25:501. CrossRef
192. RayME, LawrenceTS. Radiation therapy for aggressive fibromatosis (desmoid tumor). J Clin Oncol2006;24:3714. CrossRef
193. ChatzipetrouMA, TzakisAG, PinnaAD, et al.Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis. Surgery2001;129:277. CrossRef
194. Al‐TassanN, ChmielNH, MaynardJ, et al.Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet2002;30:227. CrossRef
195. ClearySP, CotterchioM, JenkinsMA, et al.Germline MutY human homologue mutations and colorectal cancer: a multisite case‐control study. Gastroenterology2009;136:1251. CrossRef
196. SieberOM, LiptonL, CrabtreeM, et al.Multiple colorectal adenomas, classic adenomatous polyposis, and germ‐line mutations in MYH. N Engl J Med2003;348:791. CrossRef
197. WangL, BaudhuinLM, BoardmanLA, et al.MYH mutations in patients with attenuated and classic polyposis and with young‐onset colorectal cancer without polyps. Gastroenterology2004;127:9. CrossRef
198. JoW‐S, BandipalliamP, ShannonKM, et al.Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol2005;3:1022. CrossRef
199. SampsonJR, DolwaniS, JonesS, et al.Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet2003;362:39. CrossRef
200. JonesS, EmmersonP, MaynardJ, et al.Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet2002;11:2961. CrossRef
201. VenesioT, MolatoreS, CattaneoF, et al.High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology2004;126:1681. CrossRef
202. EnholmS, HienonenT, SuomalainenA, et al.Proportion and phenotype of MYH‐associated colorectal neoplasia in a population‐based series of Finnish colorectal cancer patients. Am J Pathol2003;163:827. CrossRef
203. FarringtonSM, TenesaA, BarnetsonR, et al.Germline susceptibility to colorectal cancer due to base‐excision repair gene defects. Am J Hum Genet2005;77:112. CrossRef
204. KnoppertsAP, NielsenM, NiessenRC, et al.Contribution of bi‐allelic germline MUTYH mutations to early‐onset and familial colorectal cancer and to low number of adenomatous polyps: case‐series and literature review. Fam Cancer2013;12:43. CrossRef
205. FilipeB, BaltazarC, AlbuquerqueC, et al.APC or MUTYH mutations account for the majority of clinically well‐characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas. Clin Genet2009;76:242. CrossRef
206. NielsenM, MorreauH, VasenHFA, et al.MUTYH‐associated polyposis (MAP). Crit Rev Oncol Hematol2011;79:1. CrossRef
207. LiptonL, TomlinsonI. The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. Clin Gastroenterol Hepatol2004;2:633. CrossRef
208. HalfordSE, RowanAJ, LiptonL, et al.Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. Am J Pathol2003;162:1545. CrossRef
209. LiptonL, HalfordSE, JohnsonV, et al.Carcinogenesis in MYH‐associated polyposis follows a distinct genetic pathway. Cancer Res2003;63:7595.
210. BurtRW, BarthelJS, DunnKB, et al.NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw2010;8:8.
211. NielsenM, van SteenbergenLN, JonesN, et al.Survival of MUTYH‐Associated Polyposis Patients With Colorectal Cancer and Matched Control Colorectal Cancer Patients. J Natl Cancer Inst2010;102:1724. CrossRef
212. BoparaiKS, DekkerE, Van EedenS, et al.Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH‐associated polyposis. Gastroenterology2008;135:2014. CrossRef
213. BuchananD, YoungJ. A perspective on bi‐allelic MUTYH mutations in patients with hyperplastic polyposis syndrome. Gastroenterology2009;136:2407. CrossRef
214. VogtS, JonesN, ChristianD, et al.Expanded extracolonic tumor spectrum in MUTYH‐associated polyposis. Gastroenterology2009;137:1976. CrossRef
215. SouthCD, HampelH, ComerasI, et al.The frequency of Muir‐Torre syndrome among Lynch syndrome families. J Natl Cancer Inst2008;100:277. CrossRef
216. BurtR, JassJR. Hyperplastic polyposis. In: HamiltonSR, AaltonenLA(eds). World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 135.
217. SnoverDC, AhnenDJ, BurtRW, et al.Serrated polyps of the colon and rectum and serrated polyposis. In: BosmanFT, CarneiroF, HrubanRH, et al. (eds). WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer (IARC); 2010: 160.
218. GuarinosC, Sanchez‐FortunC, Rodriguez‐SolerM, et al.Serrated polyposis syndrome: molecular, pathological and clinical aspects. World J Gastroenterol2012;18:2452. CrossRef
219. OrlowskaJ. Hyperplastic polyposis syndrome and the risk of colorectal cancer. Gut2012;61:470. CrossRef
220. BiswasS, EllisAJ, GuyR, et al.High prevalence of hyperplastic polyposis syndrome (serrated polyposis) in the NHS bowel cancer screening programme. Gut2013;62:475. CrossRef
221. MoreiraL, PelliséM, CarballalS, et al.High prevalence of serrated polyposis syndrome in FIT‐based colorectal cancer screening programmes. Gut2013;62:476. CrossRef
222. WalkerRG, LandmannJK, HewettDG, et al.Hyperplastic polyposis syndrome is associated with cigarette smoking, which may be a modifiable risk factor. Am J Gastroenterol2010;105:1642. CrossRef
223. KaladyMF, JarrarA, LeachB, et al.Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum2011;54:164. CrossRef
224. WinAK, WaltersRJ, BuchananDD, et al.Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol2012;107:770. CrossRef
225. LanspaSJ, AhnenDJ, LynchHT. Editorial: serrated polyposis: the last (or only the latest?) frontier of familial polyposis?Am J Gastroenterol2012;107:779. CrossRef
226. RostyC, ParryS, YoungJP. Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Pathol Res Int2011;2011:157073. CrossRef
227. BoparaiKS, Mathus‐VliegenEM, KoornstraJJ, et al.Increased colorectal cancer risk during follow‐up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut2010;59:1094. CrossRef
228. RostyC, BuchananDD, WalshMD, et al.Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol2012;36:876. CrossRef
229. BuchananDD, SweetK, DriniM, et al.Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis2010;25:703. CrossRef
230. RostyC, WalshMD, WaltersRJ, et al.Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol2013;37:434. CrossRef
231. EdelsteinDL, AxilbundJE, HylindLM, et al.Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut2013;62:404. CrossRef
232. BoparaiKS, ReitsmaJB, LemmensV, et al.Increased colorectal cancer risk in first‐degree relatives of patients with hyperplastic polyposis syndrome. Gut2010;59:1222. CrossRef
233. HazewinkelY, ReitsmaJB, NagengastFM, et al.Extracolonic cancer risk in patients with serrated polyposis syndrome and their first‐degree relatives. Fam Cancer2013;12:669. CrossRef
234. OquinenaS, GuerraA, PueyoA, et al.Serrated polyposis: prospective study of first‐degree relatives. Eur J Gastroenterol Hepatol2013;25:28. CrossRef
235. National Comprehensive Cancer Network. Colorectal Cancer Screening, NCCN Guidelines Version 1.; 2013; Available at: http://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf. Accessed May 2014.
236. JeghersH, McKusickVA, KatzKH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. A syndrome of diagnostic significance. N Engl J Med1949;241:993. CrossRef
237. BeggsAD, LatchfordAR, VasenHF, et al.Peutz‐Jeghers syndrome: a systematic review and recommendations for management. Gut2010;59:975. CrossRef
238. SchreibmanIR, BakerM, AmosC, et al.The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol2005;100:476. CrossRef
239. JaspersonK, KohlmannW, BurtR. Inherited risk for colorectal cancer: practical approaches for identification, referral and management. Pract Gastroenterol2007;31:37.
240. GiardielloFM, TrimbathJD. Peutz‐Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol2006;4:408. CrossRef
241. HearleN, SchumacherV, MenkoFH, et al.Frequency and spectrum of cancers in the Peutz‐Jeghers syndrome. Clin Cancer Res2006;12:3209. CrossRef
242. McGarrityTJ, KulinHE, ZainoRJ. Peutz‐Jeghers syndrome. Am J Gastroenterol2000;95:596. CrossRef
243. AmosCI, Keitheri‐CheteriMB, SabripourM, et al.Genotype‐phenotype correlations in Peutz‐Jeghers syndrome. J Med Genet2004;41:327. CrossRef
244. van LierMG, Mathus‐VliegenEM, WagnerA, et al.High cumulative risk of intussusception in patients with peutz‐jeghers syndrome: time to update surveillance guidelines?Am J Gastroenterol2011;106:940. CrossRef
245. CalvaD, HoweJR. Hamartomatous polyposis syndromes. Surg Clin North Am2008;88:779. CrossRef
246. GammonA, JaspersonK, KohlmannW, et al.Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol2009;23:219. CrossRef
247. MehenniH, RestaN, ParkJG, et al.Cancer risks in LKB1 germline mutation carriers. Gut2006;55:984. CrossRef
248. van LierMG, WagnerA, Mathus‐VliegenEM, et al.High cancer risk in Peutz‐Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol2010;105:1258. CrossRef
249. GiardielloFM, BrensingerJD, TersmetteAC, et al.Very high risk of cancer in familial Peutz‐Jeghers syndrome. Gastroenterology2000;119:1447. CrossRef
250. LimW, OlschwangS, KellerJJ, et al.Relative frequency and morphology of cancers in stk11 mutation carriers. Gastroenterology2004;126:1788. CrossRef
251. YouYN, WolffBG, BoardmanLA, et al.Peutz‐Jeghers syndrome: a study of long‐term surgical morbidity and causes of mortality. Fam Cancer2010;9:609. CrossRef
252. UlbrightTM, AminMB, YoungRH. Intratubular large cell hyalinizing sertoli cell neoplasia of the testis: a report of 8 cases of a distinctive lesion of the Peutz‐Jeghers syndrome. Am J Surg Pathol2007;31:827. CrossRef
253. AretzS, StienenD, UhlhaasS, et al.High proportion of large genomic STK11 deletions in Peutz‐Jeghers syndrome. Hum Mutat2005;26:513. CrossRef
254. VolikosE, RobinsonJ, AittomakiK, et al.LKB1 exonic and whole gene deletions are a common cause of Peutz‐Jeghers syndrome. J Med Genet2006;43:e18. CrossRef
255. MehenniH, RestaN, GuantiG, et al.Molecular and clinical characteristics in 46 families affected with Peutz‐Jeghers syndrome. Dig Dis Sci2007;52:1924. CrossRef
256. MarignaniPA. LKB1, the multitasking tumour suppressor kinase. J Clin Pathol2005;58:15. CrossRef
257. AmaroR, DiazG, SchneiderJ, et al.Peutz‐Jeghers syndrome managed with a complete intraoperative endoscopy and extensive polypectomy. Gastrointest Endosc2000;52:552. CrossRef
258. ParsiMA, BurkeCA. Utility of capsule endoscopy in Peutz‐Jeghers syndrome. Gastrointest Endosc Clin N Am2004;14:159. CrossRef
259. BurkeCA, SantisiJ, ChurchJ, et al.The utility of capsule endoscopy small bowel surveillance in patients with polyposis. Am J Gastroenterol2005;100:1498. CrossRef
260. OhmiyaN, TaguchiA, ShiraiK, et al.Endoscopic resection of Peutz‐Jeghers polyps throughout the small intestine at double‐balloon enteroscopy without laparotomy. Gastrointest Endosc2005;61:140. CrossRef
261. MayA, NachbarL, EllC. Double‐balloon enteroscopy (push‐and‐pull enteroscopy) of the small bowel: feasibility and diagnostic and therapeutic yield in patients with suspected small bowel disease. Gastrointest Endosc2005;62:62. CrossRef
262. UddL, KatajistoP, RossiDJ, et al.Suppression of Peutz–Jeghers polyposis by inhibition of cyclooxygenase‐2. Gastroenterology2004;127:1030. CrossRef
263. WeiC, AmosCI, ZhangN, et al.Suppression of Peutz‐Jeghers polyposis by targeting mammalian target of rapamycin signaling. Clin Cancer Res2008;14:1167. CrossRef
264. NikitakisNG, KoumakiD. Laugier‐Hunziker syndrome: case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol2013;116:e52. CrossRef
265. RangwalaS, DohertyCB, KattaR. Laugier‐Hunziker syndrome: a case report and review of the literature. Dermatol Online J2010;16:9.
266. ZacharinM, BajpaiA, ChowCW, et al.Gastrointestinal polyps in McCune Albright syndrome. J Med Genet2011;48:458. CrossRef
267. LatchfordAR, NealeK, PhillipsRK, et al.Juvenile polyposis syndrome: a study of genotype, phenotype, and long‐term outcome. Dis Colon Rectum2012;55:1038. CrossRef
268. ChowE, MacraeF. A review of juvenile polyposis syndrome. J Gastroenterol Hepatol2005;20:1634. CrossRef
269. BoardmanLA. Heritable colorectal cancer syndromes: recognition and preventive management. Gastroenterol Clin North Am2002;31:1107. CrossRef
270. DelnatteC, SanlavilleD, MougenotJF, et al.Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor‐suppressor genes. Am J Hum Genet2006;78:1066. CrossRef
271. GallioneCJ, RepettoGM, LegiusE, et al.A combined syndrome of juvenile polyposis and hereditary hemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet2004;363:852. CrossRef
272. O'MalleyM, LaguardiaL, KaladyMF, et al.The prevalence of hereditary hemorrhagic telangiectasia in juvenile polyposis syndrome. Dis Colon Rectum2012;55:886. CrossRef
273. GallioneC, AylsworthAS, BeisJ, et al.Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP‐HHT syndrome. Am J Med Genet A2010;152A:333. CrossRef
274. AretzS, StienenD, UhlhaasS, et al.High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet2007;44:702. CrossRef
275. BrosensLA, van HattemA, HylindLM, et al.Risk of colorectal cancer in juvenile polyposis. Gut2007;56:965. CrossRef
276. AaltonenLA, JassJR, HoweJR. Juvenile polyposis. In: HamiltonSR, AaltonenLA(eds). World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 130.
277. WirtzfeldDA, PetrelliNJ, Rodriguez‐BigasMA. Hamartomatous polyposis syndromes: molecular genetics, neoplastic risk, and surveillance recommendations. Ann Surg Oncol2001;8:319. CrossRef
278. Calva‐CerqueiraD, DahdalehFS, WoodfieldG, et al.Discovery of the BMPR1A promoter and germline mutations that cause juvenile polyposis. Hum Mol Genet2010;19:4654. CrossRef
279. van HattemWA, BrosensLA, de LengWW, et al.Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut2008;57:623. CrossRef
280. HeXC, ZhangJ, TongWG, et al.BMP signaling inhibits intestinal stem cell self‐renewal through suppression of Wnt‐beta‐catenin signaling. Nat Genet2004;36:1117. CrossRef
281. HardwickJC, Van Den BrinkGR, BleumingSA, et al.Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology2004;126:111. CrossRef
282. OncelM, ChurchJM, RemziFH, et al.Colonic surgery in patients with juvenile polyposis syndrome: a case series. Dis Colon Rectum2005;48:49. CrossRef
283. LachlanKL, LucassenAM, BunyanD, et al.Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age‐related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet2007;44:579. CrossRef
284. PilarskiR. Cowden syndrome: a critical review of the clinical literature. J Genet Couns2008;18:13. CrossRef
285. EngC, EngC, BurtRW. Cowden syndrome. In: BosmanFT, CarneiroF, HrubanRH, et al. (eds). WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer (IARC); 2010: 171.
286. PilarskiR, StephensJA, NossR, et al.Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan‐Riley‐Ruvalcaba syndrome clinical features. J Med Genet2011;48:505. CrossRef
287. TanMH, MesterJL, NgeowJ, et al.Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res2012;18:400. CrossRef
288. EngC. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet2000;37:828. CrossRef
289. National Comprehensive Cancer Network. Genetic/familial high‐risk assessment: breast and ovarian, NCCN Guidelines Version 2.2013. National Comprehensive Cancer Network; 2013; Available at: http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. Accessed May 2014.
290. PilarskiR, EngC. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet2004;41:323. CrossRef
291. HealdB, MesterJ, RybickiL, et al.Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology2010;139:1927. CrossRef
292. StanichPP, OwensVL, SweetserS, et al.Colonic polyposis and neoplasia in Cowden syndrome. Mayo Clin Proc2011;86:489. CrossRef
293. TrufantJW, GreeneL, CookDL, et al.Colonic ganglioneuromatous polyposis and metastatic adenocarcinoma in the setting of Cowden syndrome: a case report and literature review. Hum Pathol2012;43:601. CrossRef
294. LeviZ, BarisHN, KedarI, et al.Upper and lower gastrointestinal findings in PTEN mutation‐positive cowden syndrome patients participating in an active surveillance program. Clin Transl Gastroenterol2011;2:e5. CrossRef
295. PilarskiR. Cowden syndrome: a critical review of the clinical literature. J Genet Couns2009;18:13. CrossRef
296. Riegert‐JohnsonDL, GleesonFC, RobertsM, et al.Cancer and Lhermitte‐Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract2010;8:6. CrossRef
297. McGarrityTJ, Wagner BakerMJ, RuggieroFM, et al.GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations. Am J Gastroenterol2003;98:1429. CrossRef
298. Al‐ThihliK, PalmaL, MarcusV, et al.A case of Cowden's syndrome presenting with gastric carcinomas and gastrointestinal polyposis. Nat Clin Pract Gastroenterol Hepatol2009;6:184. CrossRef
299. TanMH, MesterJ, PetersonC, et al.A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet2011;88:42. CrossRef
300. RobinsonS, CohenAR. Cowden disease and Lhermitte‐Duclos disease: an update. Case report and review of the literature. Neurosurg Focus2006;20:E6. CrossRef
301. GorlinRJ, CohenMMJr, CondonLM, et al.Bannayan‐Riley‐Ruvalcaba syndrome. Am J Med Genet1992;44:307. CrossRef
302. LowichikA, WhiteFV, TimmonsCF, et al.Bannayan‐Riley‐Ruvalcaba syndrome: spectrum of intestinal pathology including juvenile polyps. Pediatr Dev Pathol2000;3:155. CrossRef
303. AgaimyA, VassosN, CronerRS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol2012;5:852.
304. WilliamsVC, LucasJ, BabcockMA, et al.Neurofibromatosis type 1 revisited. Pediatrics2009;123:124. CrossRef
305. RellesD, BaekJ, WitkiewiczA, et al.Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20‐year review of the literature yielding 76 cases. J Gastrointest Surg2010;14:1052. CrossRef
306. HochbergFH, DasilvaAB, GaldabiniJ, et al.Gastrointestinal involvement in von Recklinghausen's neurofibromatosis. Neurology1974;24:1144. CrossRef
307. ShekitkaKM, SobinLH. Ganglioneuromas of the gastrointestinal tract. Relation to Von Recklinghausen disease and other multiple tumor syndromes. Am J Surg Pathol1994;18:250. CrossRef
308. OzcinarB, AksakalN, AgcaogluO, et al.Multiple gastrointestinal stromal tumors and pheochromocytoma in a patient with von Recklinghausen's disease. Int J Surg Case Rep2013;4:216. CrossRef
309. MaertensO, PrenenH, Debiec‐RychterM, et al.Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet2006;15:1015. CrossRef
310. WimmerK, EtzlerJ. Constitutional mismatch repair‐deficiency syndrome: have we so far seen only the tip of an iceberg?Hum Genet2008;124:105. CrossRef
311. HerkertJC, NiessenRC, Olderode‐BerendsMJ, et al.Paediatric intestinal cancer and polyposis due to bi‐allelic PMS2 mutations: case series, review and follow‐up guidelines. Eur J Cancer2011;47:965. CrossRef
312. MartuccielloG, LeroneM, BriccoL, et al.Multiple endocrine neoplasias type 2B and RET proto‐oncogene. Ital J Pediatr2012;38:9. CrossRef
313. MarshDJ, MulliganLM, EngC. RET proto‐oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Horm Res1997;47:168. CrossRef
314. CarterJE, LauriniJA. Isolated intestinal neurofibromatous proliferations in the absence of associated systemic syndromes. World J Gastroenterol2008;14:6569. CrossRef
315. NgKH, MathurP, KumarasingheMP, et al.Cap polyposis: further experience and review. Dis Colon Rectum2004;47:1208. CrossRef
316. IsomotoH, UrataM, NakagoeT, et al.Proximal extension of cap polyposis confirmed by colonoscopy. Gastrointest Endosc2001;54:388. CrossRef
317. BrosensLA, MontgomeryEA, BhagavanBS, et al.Mucosal prolapse syndrome presenting as rectal polyposis. J Clin Pathol2009;62:1034. CrossRef
318. EsakiM, MatsumotoT, KobayashiH, et al.Cap polyposis of the colon and rectum: an analysis of endoscopic findings. Endoscopy2001;33:262. CrossRef
319. GallegosM, LauC, BradlyDP, et al.Cap polyposis with protein‐losing enteropathy. Gastroenterol Hepatol (N Y)2011;7:415.
320. DehghaniSM, MalekpourA, HaghighatM. Solitary rectal ulcer syndrome in children: a literature review. World J Gastroenterol2012;18:6541. CrossRef
321. AbidS, KhawajaA, BhimaniSA, et al.The clinical, endoscopic and histological spectrum of the solitary rectal ulcer syndrome: a single‐center experience of 116 cases. BMC Gastroenterol2012;12:72. CrossRef
322. BastleinC, BurlefingerR, HolzbergE, et al.Common variable immunodeficiency syndrome and nodular lymphoid hyperplasia in the small intestine. Endoscopy1988;20:272. CrossRef
323. SharmaM, GoyalA, EckaRS. An unusual cause of recurrent diarrhea with small intestinal "polyposis". Nodular lymphoid hyperplasia of the small intestine. Gastroenterology2012;142:e8. CrossRef
324. MolaeiM, KaboliA, FathiAM, et al.Nodular lymphoid hyperplasia in common variable immunodeficiency syndrome mimicking familial adenomatous polyposis on endoscopy. Indian J Pathol Microbiol2009;52:530. CrossRef
325. JooM, ShimSH, ChangSH, et al.Nodular lymphoid hyperplasia and histologic changes mimicking celiac disease, collagenous sprue, and lymphocytic colitis in a patient with selective IgA deficiency. Pathol Res Pract2009;205:876. CrossRef
326. GargV, LipkaS, RizvonK, et al.Diffuse nodular lymphoid hyperplasia of intestine in selective IgG 2 subclass deficiency, autoimmune thyroiditis, and autoimmune hemolytic anemia: case report and literature review. J Gastrointestin Liver Dis2012;21:431.
327. CastellanoG, MorenoD, GalvaoO, et al.Malignant lymphoma of jejunum with common variable hypogammaglobulinemia and diffuse nodular hyperplasia of the small intestine. A case study and literature review. J Clin Gastroenterol1992;15:128. CrossRef
328. AtwellJD, BurgeD, WrightD. Nodular lymphoid hyperplasia of the intestinal tract in infancy and childhood. J Pediatr Surg1985;20:25. CrossRef
329. MansuetoP, IaconoG, SeiditaA, et al.Review article: intestinal lymphoid nodular hyperplasia in children – the relationship to food hypersensitivity. Aliment Pharmacol Ther2012;35:1000.
330. Lai Ping SoA, MayerL. Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis1997;8:22.
331. SchwartzDC, ColeCE, SunY, et al.Diffuse nodular lymphoid hyperplasia of the colon: polyposis syndrome or normal variant?Gastrointest Endosc2003;58:630.
332. BharadhwajG, TriadafilopoulosG. Endoscopic appearances of colonic lymphoid nodules: new faces of an old histopathological entity. Am J Gastroenterol1995;90:946.
333. NagasakoK, TakemotoT. Endoscopy of the ileocecal area. Gastroenterology1973;65:403.
334. NagaokaS, BandohT, TakemuraT. Lymphoid hyperplasia of the large intestine: a case report with immunohistochemical and gene analysis. Pathol Int2000;50:750. CrossRef
335. FossHD, SteinH. Pathology of intestinal lymphomas. Recent Results Cancer Res2000;156:33. CrossRef
336. Ruskone‐FourmestrauxA. Gastrointestinal lymphomas: the French experience of the Groupe D'etude des Lymphomes Digestifs (GELD). Recent Results Cancer Res2000;156:99. CrossRef
337. KellaVK, ConstantineR, ParikhNS, et al.Mantle cell lymphoma of the gastrointestinal tract presenting with multiple intussusceptions–case report and review of literature. World J Surg Oncol2009;7:60. CrossRef
338. TamuraS, OhkawauchiK, YokoyamaY, et al.Non‐multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract. J Gastroenterol2004;39:995. CrossRef
339. OkazakiK. Multiple lymphomatous polyposis form is common but not specific for mantle cell lymphoma in the gastrointestinal tract. J Gastroenterol2004;39:1023. CrossRef
340. Ruskone‐FourmestrauxA, DelmerA, LavergneA, et al.Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'etude des Lymphomes Digestifs. Gastroenterology1997;112:7. CrossRef
341. RodriguesS, CardosoH, MacedoG. Mantle cell lymphoma presenting as multiple lymphomatous polyposis of the small bowel. Clin Gastroenterol Hepatol2013;11:e71. CrossRef
342. PalsST, DrillenburgP, DragosicsB, et al.Expression of the mucosal homing receptor alpha 4 beta 7 in malignant lymphomatous polyposis of the intestine. Gastroenterology1994;107:1519. CrossRef
343. EndohM, HiraishiH, TeranoA. Gastrointestinal: multiple lymphomatous polyposis. J Gastroenterol Hepatol1999;14:937. CrossRef
344. ShenKH, ChenCJ, YenHH. Multiple polyposis of the esophagus: mantle cell lymphoma. Clin Gastroenterol Hepatol2012;10:e65. CrossRef
345. MynsterT, HultbergB, BulowS. Multiple lymphomatous polyposis of the colon and rectum. Scand J Gastroenterol1994;29:545. CrossRef
346. XuXJ, WuSM. Multiple lymphomatous polyposis of the gastrointestinal tract: report of three cases and literature review. J Dig Dis2012;13:649. CrossRef
347. YanaiS, NakamuraS, TakeshitaM, et al.Translocation t(14;18)/IGH‐BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients. Cancer2011;117:2467. CrossRef
348. Al‐SaleemT, Al‐MondhiryH. Immunoproliferative small intestinal disease (IPSID): a model for mature B‐cell neoplasms. Blood2005;105:2274. CrossRef
349. LecuitM, AbachinE, MartinA, et al.Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med2004;350:239. CrossRef
350. MesnardB, De VroeyB, MaunouryV, et al.Immunoproliferative small intestinal disease associated with Campylobacter jejuni. Dig Liver Dis2012;44:799. CrossRef
351. ErsoyO, AkinE, DemirezerA, et al.Capsule‐endoscopic findings in immunoproliferative small‐intestinal disease. Endoscopy2012;44:UCTN:E61. CrossRef
352. DuttaU, UdawatH, NoorMT, et al.Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. J Gastrointest Cancer2010;41:212. CrossRef
353. DurnoCA, HolterS, ShermanPM, et al.The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations. Am J Gastroenterol2010;105:2449. CrossRef
354. JaspersonKW. Genetic testing by cancer site: colon (polyposis syndromes). Cancer J2012;18:328. CrossRef
355. DurnoCA, AronsonM, TaboriU, et al.Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow‐up of a kindred. Pediatr Blood Cancer2012;59:652. CrossRef
356. JaegerEE, Woodford‐RichensKL, LockettM, et al.An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13‐q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet2003;72:1261. CrossRef
357. RozenP, SamuelZ, BrazowskiE. A prospective study of the clinical, genetic, screening, and pathologic features of a family with hereditary mixed polyposis syndrome. Am J Gastroenterol2003;98:2317. CrossRef
358. JaegerE, WebbE, HowarthK, et al.Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet2008;40:26. CrossRef
359. JaegerE, LeedhamS, LewisA, et al.Hereditary mixed polyposis syndrome is caused by a 40‐kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet2012;44:699. CrossRef
360. SweetserS, AhlquistDA, OsbornNK, et al.Clinicopathologic features and treatment outcomes in Cronkhite‐Canada syndrome: support for autoimmunity. Dig Dis Sci2012;57:496. CrossRef
361. SeshadriD, KaragiorgosN, HyserMJ. A case of cronkhite‐Canada syndrome and a review of gastrointestinal polyposis syndromes. Gastroenterol Hepatol (N Y)2012;8:197.
362. SweetserS, BoardmanLA. Cronkhite‐Canada syndrome: an acquired condition of gastrointestinal polyposis and dermatologic abnormalities. Gastroenterol Hepatol (N Y)2012;8:201.
363. SamohaS, ArberN. Cronkhite‐Canada syndrome. Digestion2005;71:199. CrossRef
364. BlonskiWC, FurthEE, KinosianBP, et al.A case of Cronkhite‐Canada syndrome with taste disturbance as a leading complaint. Digestion2005;71:201. CrossRef
365. FreniSC, KeemanJN. Leiomyomatosis of the colon. Cancer1977;39:263. CrossRef
366. SpaunE, NielsenL. Leiomyomatosis of the colon and mesentery: report of a case. Am J Gastroenterol1986;81:385.
367. VallaeysJH, CuvelierCA, BekaertL, et al.Combined leiomyomatosis of the small intestine and colon. Arch Pathol Lab Med1992;116:281.
368. CrouchG, DevittPG, ThompsonSK. Diffuse esophageal leiomyomatosis. Dis Esophagus2011;24:145. CrossRef
369. SellHWJr, CoccoA. Diffuse leiomyomatosis of the gastrointestinal tract in a single patient–esophagus to rectum: case report. Surgery1997;122:637. CrossRef
370. Santos‐BrizA, GarciaJP, GonzalezC, et al.Lipomatous polyposis of the colon. Histopathology2001;38:81. CrossRef
371. Zarrin‐KhamehN, HaasEM, RoJ, et al.Lipomatosis coli, a mimicker of familial polyposis. Ann Diagn Pathol2013;17:210. CrossRef
372. BroulandJP, PoupardB, NemethJ, et al.Lipomatous polyposis of the colon with multiple lipomas of peritoneal folds and giant diverticulosis: report of a case. Dis Colon Rectum2000;43:1767. CrossRef
373. TatsuguchiA, FukudaY, MoriyamaT, et al.Lipomatosis of the small intestine and colon associated with intussusception in the ileocecal region. Gastrointest Endosc1999;49:118. CrossRef
374. WatanabeT, KatoK, SugitaniM, et al.A case of multiple lymphangiomas of the colon suggesting colonic lymphangiomatosis. Gastrointest Endosc2000;52:781. CrossRef
375. JungSW, ChaJM, LeeJI, et al.A case report with lymphangiomatosis of the colon. J Korean Med Sci2010;25:155. CrossRef
376. AttarA, PocardM, MessingB. Pneumatosis cystoides intestinalis in primary intestinal pseudo‐obstruction: a nonsurgical cause of pneumoperitoneum. Clin Gastroenterol Hepatol2005;3:A21. CrossRef
377. KhalilPN, Huber‐WagnerS, LadurnerR, et al.Natural history, clinical pattern, and surgical considerations of pneumatosis intestinalis. Eur J Med Res2009;14:231. CrossRef